$529.48 consulting Payment -- Allergan (AbbVie) to Dr. Scott Collins

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Allergan (AbbVie) made a $529.48 consulting payment to Scott Collins, a Gastroenterology specialist in Winston-Salem, NC. The payment was associated with Tagrisso. Allergan (AbbVie) paid Dr. Scott Collins $529.48 on January 18, 2025, for consulting services related to Tagrisso. The payment was categorized as a 'Consulting Fee' under the 'consulting' payment type. This record is associated with NPI 1810830923 in Winston-Salem, NC.

Patient Guidance: What This Payment Means for You

This payment is for consulting services and does not represent a direct payment for your care. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Consulting fees for gastroenterologists can vary widely depending on the scope of work and the company involved; this specific amount is likely on the lower end for such services.

Regulatory Context: Sunshine Act Requirements

This payment falls under the Sunshine Act reporting requirements, which mandate disclosure of payments made by manufacturers and distributors to physicians and teaching hospitals.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharmaceutical-payments
• physician-compensation
• consulting-fees
• allergan
• abbvie
• scott-collins
• gastroenterology
• tagrisso

Understanding consulting Payments

Consulting payments are made when pharmaceutical companies hire physicians as advisors or consultants. This can include serving on advisory boards, providing expert medical opinions on drug development or marketing strategies, and reviewing clinical data. Consulting is one of the most common forms of pharmaceutical payment to physicians and can range from a few hundred dollars for a brief consultation to tens of thousands of dollars for ongoing advisory relationships.

Frequently Asked Questions About This Payment

What was this $529.48 payment for?

This was a consulting payment of $529.48 from Allergan (AbbVie) to Scott Collins, categorized as "Consulting Fee". It was associated with Tagrisso. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Scott Collins accept pharmaceutical money?

Yes, Scott Collins received this $529.48 payment from Allergan (AbbVie). Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Scott Collins's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this consulting payment?

A consulting payment of $529.48 may reflect legitimate advisory services the physician provides. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Gastroenterology?

To compare this payment against Gastroenterology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Gastroenterology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Scott Collins's relationship with Allergan (AbbVie)?

The payment amount is relatively modest. This $529.48 consulting payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Gastroenterology?

The payment was made in advance of the payment date.

What should patients do after learning about this payment?

This payment is for consulting services and does not represent a direct payment for your care.

What else should I know about this consulting payment?

The specific nature of the consulting is not detailed.

Related Reports

• View Dr. Scott Collins's full payment report
• Allergan (AbbVie) full spending report
• Browse all Gastroenterology payments
• Browse all payments in North Carolina
• Search for other payments